The most common side effects are nausea, diarrhoea, constipation, vomiting, indigestion and abdominal discomfort
doi:10.2147/DMSO.S244850 This review provides insights into the comparative efficacy, safety, and cardiovascular outcomes of once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes, which might include data on blood pressure effects
However, the onset time to effect may differ
These therapies have the potential to restore intestinal integrity, enhance nutrient absorption, and support overall well-being
Receive a Personalized Plan Your provider creates a plan that may include nutrition guidance, lifestyle counseling, and prescription treatment when appropriate